We aimed to study the predictive value of combined 18F-fluoro-deoxy-D-glucose positron emission tomography and computerized tomography (FDG-PET-CT), on outcomes in locally advanced pancreatic carcinoma (LAPC) patients treated with concurrent chemoradiotherapy (C-CRT).
Background/Objectives: Current developments in computer-aided systems rely heavily on complex and computationally intensive algorithms. However, even a simple approach can offer a promising solution to reduce the burden on clinicians. Addressing this, we aim to employ unsupervised cluster analysis to identify prognostic subgroups of non-small-cell lung cancer (NSCLC) patients with brain metastasis (BM). Simple-yet-effective algorithms designed to identify similar group characteristics will assist clinicians in categorizing patients effectively. Methods: We retrospectively collected data from 95 NSCLC patients with BM treated at two oncology centers. To identify clinically distinct subgroups, two types of unsupervised clustering methods—two-step clustering (TSC) and hierarchical cluster analysis (HCA)—were applied to the baseline clinical data. Patients were categorized into prognostic classes according to the Diagnosis-Specific Graded Prognostic Assessment (DS-GPA). Survival curves for the clusters and DS-GPA classes were generated using Kaplan–Meier analysis, and the differences were assessed with the log-rank test. The discriminative ability of three categorical variables on survival was compared using the concordance index (C-index). Results: The mean age of the patients was 61.8 ± 0.9 years, and the majority (77.9%) were men. Extracranial metastasis was present in 71.6% of the patients, with most (63.2%) having a single BM. The DS-GPA classification significantly divided the patients into prognostic classes (p < 0.001). Furthermore, statistical significance was observed between clusters created by TSC (p < 0.001) and HCA (p < 0.001). HCA showed the highest discriminatory power (C-index = 0.721), followed by the DS-GPA (C-index = 0.709) and TSC (C-index = 0.650). Conclusions: Our findings demonstrated that the TSC and HCA models were comparable in prognostic performance to the DS-GPA index in NSCLC patients with BM. These results suggest that unsupervised clustering may offer a data-driven perspective on patient stratification, though further validation is needed to clarify its role in prognostic modeling.
1 January 2022 in Eurasian Journal of Medical Investigation
Objective: To evaluate the efficacy of thoracic radiotherapy to primary site in patients with extensive stage small cell lung cancer (SCLC) who had responded completely to systemic chemotherapy. Study Design: Observational study.Place and Duration of Study: Departments of Radiation and Medical Oncology, Baskent University and Dr. Ersin Arslan Research and Training Hospital in Turkey, between the years of 2011 and 2020. Methodology: The study included 125 patients with extensive stage SCLC. Demographic data and outcomes of chemotherapy and radiotherapy were collected. The efficacy of thoracic radiotherapy to primary site was evaluated in patients who had responded completely to systemic chemotherapy, in terms of progression-free survival and overall survival (OS).Results: The median follow-up time was 12 months and 98 (78.4%) patients died during follow-up. Seventy-three (58.4%) patients had complete response. Progression-free survival (PFS) for complete responder patients was 8 months, and OS for the whole group was found 13 months. Twenty (16%) patients received thoracic radiotherapy to primary site after complete response to platinum etoposide combination treatment. Patients receiving thoracic radiotherapy had better OS than those who did not (19 versus 12 months respectively and p=0.002). Patients receiving thoracic radiotherapy had better PFS than those who did not (11 versus 8 months, respectively, and p=0.01).Conclusion: Thoracic radiotherapy to primary site may improve the survival outcomes in extensive stage SCLC patients who had complete response to initial systemic chemotherapy.